IndraLab

Statements

Hydroxychloroquine decreases the amount of SIGLEC1. 2 / 3

| 2

reach

"As Lisney et al. have reported, the IFN-α-targeted therapy with anti-inflammatory hydroxychloroquine decreases Siglec-1 expression on maternal monocytes and/or macrophages and reduces risk for the development of fetal CHB [146]."

32575400

➶

reach

"SIGLEC1 and IFN-alpha expression were reduced by hydroxychloroquine and oral glucocorticoids."

28501799

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Hydroxychloroquine decreases the amount of SIGLEC1. 2 / 3

INDRA sources:

Databases

Reading